10-KPeriod: FY2013

Philip Morris International Inc. Annual Report, Year Ended Dec 31, 2013

Filed February 21, 2014For Securities:PM

Summary

Philip Morris International Inc. (PM) presents its 2013 annual report, detailing a global business focused on manufacturing and selling cigarettes and other tobacco products in markets outside the United States. The company boasts a strong portfolio of international and local brands, led by Marlboro, which accounts for a significant portion of its shipment volume. PM operates across four key geographic segments: the European Union, Eastern Europe, Middle East & Africa, Asia, and Latin America & Canada, with Asia and the EU being the largest contributors to operating companies income. Strategic initiatives during 2013 included restructuring its Egyptian business for enhanced profitability, entering into a strategic framework with Altria for the commercialization of e-cigarettes and reduced-risk tobacco products, and acquiring significant stakes in distributors and joint ventures in Russia and Algeria to strengthen market presence. The company also achieved full ownership of its Mexican tobacco business. A key strategic priority highlighted is the development of Reduced-Risk Products (RRPs), with a significant investment in a new manufacturing facility in Italy to produce these next-generation products. Despite a slight decrease in total cigarette shipments, PM maintains a substantial share of the international market, underscoring its established global footprint.

Financial Statements
Beta

Key Highlights

  • 1Philip Morris International (PM) operates exclusively outside the U.S., selling in over 180 markets with leading market share positions in many.
  • 2The company's brand portfolio is led by Marlboro, contributing approximately 33% of total 2013 shipment volume, supported by other premium and mid-price brands.
  • 3PMI's business is structured into four geographic segments: EU, EEMA, Asia, and Latin America & Canada, with Asia and the EU being the largest contributors to operating income.
  • 4Key strategic transactions in 2013 included a business restructuring in Egypt, a commercialization agreement with Altria for e-cigarettes and reduced-risk products (RRPs), and strategic investments in its Russian distributor and Algerian joint venture.
  • 5A significant focus is placed on developing Reduced-Risk Products (RRPs), with plans to invest €500 million in a new Italian manufacturing facility for RRPs, targeting commercialization by 2016.
  • 6Total cigarette shipments decreased by 5.1% in 2013, and PM's estimated international market share was 15.7%, down slightly from previous years.
  • 7The company faces substantial risks including increasing cigarette taxes, stringent governmental regulations, intense competition, litigation, currency fluctuations, and the challenges of developing and commercializing RRPs.

Frequently Asked Questions

Philip Morris International Inc. (PM) is a holding company engaged in the manufacture and sale of cigarettes and other tobacco products exclusively in markets outside the United States. Its operations are organized into four geographic segments: European Union (EU), Eastern Europe, Middle East & Africa (EEMA), Asia, and Latin America & Canada.

In 2013, PMI undertook several strategic initiatives, including restructuring its Egyptian operations, forming a strategic framework with Altria for e-cigarette and reduced-risk product commercialization, acquiring a stake in its Russian distributor (Megapolis Distribution BV), and increasing its economic interest in an Algerian joint venture (STAEM). The company also achieved 100% ownership of its Mexican tobacco business.

PMI is making a significant strategic push into Reduced-Risk Products (RRPs), aiming to develop, assess, and commercialize products with the potential to reduce the risk of smoking-related diseases compared to traditional cigarettes. The company announced a substantial investment of up to €500 million to build its first EU manufacturing facility for RRPs in Italy, with production capacity expected by 2016. This indicates a long-term commitment to diversifying its product portfolio beyond traditional cigarettes.

PMI faces significant risks including: increased cigarette taxes and duties globally, stringent government regulations driven by initiatives like the WHO's Framework Convention on Tobacco Control (FCTC), intense competition, ongoing tobacco-related litigation with potentially large damage claims, currency exchange rate volatility impacting reported earnings, and the uncertainty surrounding the successful development and regulatory approval of Reduced-Risk Products (RRPs).